Flavonoids exert anticancer effects in lung cancer by inhibiting tyrosine kinase receptors and blocking MAPK, PI3K/Akt, and JAK/STAT pathways, thereby inactivating STAT-3, suppressing transcriptional activity, and reducing cancer cell proliferation [63]. The gene discussed is AKT1; the disease is cancer.